Dublin, Aug. 15, 2023 (GLOBE NEWSWIRE) -- The "Artificial Intelligence In Cancer Diagnostics Market Size, Share & Trends Analysis Report By Component, By Cancer Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global AI in cancer diagnostics market size is expected to reach USD 996.1 million by 2030, growing at 26.3%
Driven by a convergence of pivotal factors, the growth trajectory of artificial intelligence (AI) in cancer diagnostics is poised for remarkable expansion. The imperative to curtail healthcare costs, coupled with the escalating significance of big data within the healthcare domain, sets the stage for this advancement.
The burgeoning adoption of precision medicine, complemented by the diminishing hardware expenses, adds further impetus to the growth. The burgeoning landscape witnesses AI's multifaceted applications across healthcare sectors, particularly in diagnostics.
This amplification aligns with the mounting cancer prevalence and the simultaneous shortfall in public health workforce. In tandem with these drivers, AI's transformative role in cancer care escalates, reinforced by robust venture capital investments that continue to fuel the burgeoning demand for this groundbreaking technology.
The presence of prominent players in the market such as Microsoft, Flatiron, Therapixel, and Tempus, is anticipated to positively impact the growth.
These players are adopting strategies such as acquisitions, collaborations, expansions, and new product launches to increase the reach of their products in the industry and increase the availability of their products & services in diverse geographical areas.
For instance, in December 2021, Microsoft announced a partnership with CVS Health to develop innovative solutions for patients to improve their health while empowering healthcare professionals with tools to better service patients.
Furthermore, the rising government support in the form of funding and initiatives for the development of healthcare infrastructure is anticipated to drive the demand for technologically advanced and cost-efficient devices over the forecast period.
AI In Cancer Diagnostics Market Report Highlights
- Based on component, the software solutions segment held the largest market share of 43.7% in 2022. The development of AI-based software solutions for cancer diagnostics is one of the key factors boosting segment growth
- Based on cancer type, the other cancers segment emerged as the largest segment with a revenue share of 33.6% in 2022. Growing adoption of a sedentary lifestyle increased alcohol & tobacco consumption, and physical inactivity are driving the incidence of cancers such as bladder and skin cancers
- Based on end-user, the hospital segment emerged as the largest end-user in the market, with a market share of 57.7% in 2022. The growing shortage of medical professionals and technological advancements in hospitals is expected to drive the segment
- North America dominated the global market with a share of 56.0% in 2022. The rising adoption of healthcare IT solutions, the well-established healthcare sector, and the availability of funding for developing AI capabilities are some of the factors contributing to the growth of the market in the region
Company Profiles
- EarlySign
- Cancer Center.ai
- Microsoft
- Flatiron
- Path AI
- Therapixel
- Tempus
- Paige AI Inc.
- Kheiron Medical Technologies Limited Overview
- SkinVision
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 90 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $137.8 million |
| Forecasted Market Value (USD) by 2030 | $996.1 million |
| Compound Annual Growth Rate | 26.3% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Methodology And Scope
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Regional Insight
2.4 Competitive Insights
2.5 Artificial Intelligence (Ai) In Cancer Diagnostics Market Snapshot
2.6 Artificial Intelligence (Ai) In Cancer Diagnostics Segment Snapshot
2.7 Artificial Intelligence (Ai) In Cancer Diagnostics Competitive Snapshot
Chapter 3 Artificial Intelligence (Ai) In Cancer Diagnostics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.1.1 Ai In Healthcare Market
3.1.2 Related/Ancillary Market Outlook
3.1.2.1 Artificial Intelligence In Medical Imaging Market
3.2 Penetration And Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 Artificial Intelligence (Ai) In Cancer Diagnostics Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Early Detection And Classification Of Diseases
3.4.1.2 Early Detection And Classification Of Cancer
3.4.1.3 Increasing Use Of Ai In Chronic Disease Management
3.4.1.4 Increasing Number Of Startups & Collaborations And Growing Venture Capitalist Funding
3.4.2 Market Restraint Analysis
3.4.2.1 Highly Regulated Industry
3.4.2.2 Procurement Costs And Maintenance
3.5 Artificial Intelligence In Cancer Diagnostics Market Analysis Tools
3.5.1 Industry Analysis - Porter's
3.5.2 Pestel Analysis
3.6 Impact Of The Covid-19 Pandemic On Ai In Cancer Diagnostics Market
Chapter 4 Global Artificial Intelligence (Ai) In Diagnostics Market: Competitive Analysis
4.1 Company/Competition Categorization (Key Innovators, Market Leaders, & Emerging Players)
4.2 Recent Developments, By Key Market Participants
4.3 Company Market Position Analysis
Chapter 5 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Component Estimates & Trend Analysis
5.1 Segment Dashboard
5.2 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Component Analysis, 2022 & 2030 (USD Million)
5.3 Ai In Cancer Diagnostics Market, By Component, 2017 - 2030 (USD Million)
5.4 Software Solutions
5.5 Hardware
5.6 Services
Chapter 6 Artificial Intelligence (AI) In Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis
6.1 Segment Dashboard
6.2 Artificial Intelligence (AI) In Cancer Diagnostics Market: Cancer Type Analysis, USD Million, 2022 & 2030
6.3 AI In Cancer Diagnostics Market, By Cancer Type, 2017 - 2030 (USD Million)
6.4 Breast Cancer
6.5 Lung Cancer
6.6 Prostate Cancer
6.7 Colorectal Cancer
6.8 Brain Tumor
Chapter 7 Artificial Intelligence (Ai) In Cancer Diagnostics Market: End-User Estimates & Trend Analysis
7.1 Segment Dashboard
7.2 Artificial Intelligence (Ai) In Cancer Diagnostics Market: End-User Analysis, USD Million, 2022 & 2030
7.3 Ai In Cancer Diagnostics Market, By End-User, 2017 - 2030 (USD Million)
7.4 Hospitals
7.5 Surgical Centers And Medical Institutes
Chapter 8 Artificial Intelligence (Ai) In Cancer Diagnostics Market: Regional Estimates & Trend Analysis: By Component, Cancer Type, And End-User
8.1 Regional Market Key Takeaways
8.2 Regional Market Snapshot
8.3 Growing Global Cancer Prevalence
Chapter 9 Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Competition Categorization
9.3. Company Market Position Analysis
For more information about this report visit https://www.researchandmarkets.com/r/gxbny8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
